JHS Svendgaard Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 240.53 million compared to INR 246.39 million a year ago. Revenue was INR 274.91 million compared to INR 263.32 million a year ago. Net loss was INR 2.16 million compared to net income of INR 2.66 million a year ago. Basic loss per share from continuing operations was INR 0.03 compared to basic earnings per share from continuing operations of INR 0.05 a year ago. Diluted loss per share from continuing operations was INR 0.03 compared to diluted earnings per share from continuing operations of INR 0.05 a year ago.
For the six months, sales was INR 453.62 million compared to INR 462.24 million a year ago. Revenue was INR 502.77 million compared to INR 504.95 million a year ago. Net loss was INR 40.62 million compared to net income of INR 0.405 million a year ago. Basic loss per share from continuing operations was INR 0.63 compared to basic earnings per share from continuing operations of INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.63 compared to diluted earnings per share from continuing operations of INR 0.01 a year ago.